Coagulation Enzymes, Cofactors, and Antibodies for Hemostasis and Thrombosis Research
Total Trials
1
As Lead Sponsor
As Collaborator
0
NCT01736878
Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid Carcinoma
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2012
Completion: Apr 30, 2013
Loading map...